Clinical Trial Update: Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the potential effects of SSR149415 on the hypothalamic-pituitary-adrenal axis in outpatients with major depressive disorder ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SSR149415

Snippet

Sponsor: Sanofi | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED